Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metamizole add-on therapy for pain in chronic pancreatitis
NL-OMON60138Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic pancreatitis (CP) comparing Metamizole add-on with Placebo add-on (2 arms). Primary endpoint: Mean daily pain intensity score. Started May 2024; status: recruiting.
02
Drugs
Metamizole sodium
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NL-OMON60138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60138.